Kvistgård, Denmark
Bavarian Nordic's headquarters are located in Kvistgård,
Denmark. The site houses the company's the administration, quality
control, quality assurance and production functions.
The Kvistgård facility is situated on more than 37,000
square meters of land. The buildings total approximately 8,700
square meters, of which the production area occupies about 5,870
square meters, which includes approximately 1,200 square meters for
clean rooms, and 2,870 square meters for office space and
laboratory facilities. The facility is designed, built and
qualified to manufacture IMVAMUNE® and MVA-BN® recombinant
vaccines for the European and the US markets. IMVAMUNE® is
classified as a BioSafety Level-1 (BSL-1) vaccine, but Bavarian
Nordic has also implemented additional requirements through the
design and layout of the facility so that it meets the more
stringent BSL-2 rules.
